Friday, December 11, 2009

Sunesis Pharma Continues 10-Bagger Quest (SNSS)

Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) is at it again.  The company more than doubled yesterday to $1.39 on over 35 million based upon Tuesday’s leukemia Phase II drug news presented this week.  Traders and investors are speculating that this could be the next small-cap low priced stock that could be a ten-bagger in biotech.  Shares are up 7% at $1.49 on 840,000 shares as of 8:26 AM EST.  The year high was put in yesterday at $1.84 and even after the price doubled its market cap at yesterday’s close was a mere $47.8 million.

Jon C. Ogg

No comments:

Post a Comment